Details for New Drug Application (NDA): 213116
✉ Email this page to a colleague
NDA 213116 describes TROMETHAMINE, which is a drug marketed by B Braun Medical and Milla Pharms and is included in two NDAs. It is available from two suppliers. Additional details are available on the TROMETHAMINE profile page.
The generic ingredient in TROMETHAMINE is tromethamine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the tromethamine profile page.
The generic ingredient in TROMETHAMINE is tromethamine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the tromethamine profile page.
Summary for 213116
| Tradename: | TROMETHAMINE |
| Applicant: | Milla Pharms |
| Ingredient: | tromethamine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 213116
Suppliers and Packaging for NDA: 213116
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TROMETHAMINE | tromethamine | SOLUTION;INJECTION | 213116 | ANDA | MILLA PHARMACEUTICALS INC. | 71357-001 | 71357-001-01 | 6 BOTTLE, GLASS in 1 CASE (71357-001-01) / 500 mL in 1 BOTTLE, GLASS (71357-001-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 18GM/500ML (3.6GM/100ML) | ||||
| Approval Date: | Dec 31, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
